GoldenGolden
Advanced Search
Embo (company)

Embo (company)

A marketing company that uses artificial intelligence to streamline the process of marketing for businesses and companies. It is located in San Francisco, California and was founded in 2018.

Embo is an enterprise software company that specializes in marketing visibility for businesses and other entities. It focuses on search engine optimization so that its users can expand their own clientele base by being visible when consumers search for the company on the Internet. It uses inputs, outputs, and outcomes to aid companies in reaching their potential clients and consumers.

How it works

The software uses consulting automation to calculate how companies can increase their return on investment using search engine optimization. Embo then distributes campaigns for the company to qualified marketers who use the software to develop a marketing plan.

Another feature of the software is combining the company's existing analytics with Embo's own datasets to plan a course of action for the company to be on page one of various search engines' results pages, increase traffic, and improve its return on investment.

Notable users

Some notable companies that use Embo for search engine optimization are Moogsoft, Jumio, unbounce, bloomlife, and Spiro.

Timeline

People

Name
Role
LinkedIn

Zeal Caiden

Founder and CEO

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Future Market Insights
June 10, 2021
www.prnewswire.com:443
/PRNewswire/ -- The global advanced empty capsule market sales are set to grow at over 8% CAGR during the forecast period of 2021 and 2031, estimates...
Noa Liscovitch-Brauer
April 29, 2021
Nature Biotechnology
CRISPR screens have been used to connect genetic perturbations with changes in gene expression and phenotypes. Here we describe a CRISPR-based, single-cell combinatorial indexing assay for transposase-accessible chromatin (CRISPR-sciATAC) to link genetic perturbations to genome-wide chromatin accessibility in a large number of cells. In human myelogenous leukemia cells, we apply CRISPR-sciATAC to target 105 chromatin-related genes, generating chromatin accessibility data for ~30,000 single cells. We correlate the loss of specific chromatin remodelers with changes in accessibility globally and at the binding sites of individual transcription factors (TFs). For example, we show that loss of the H3K27 methyltransferase EZH2 increases accessibility at heterochromatic regions involved in embryonic development and triggers expression of genes in the HOXA and HOXD clusters. At a subset of regulatory sites, we also analyze changes in nucleosome spacing following the loss of chromatin remodelers. CRISPR-sciATAC is a high-throughput, single-cell method for studying the effect of genetic perturbations on chromatin in normal and disease states. The effects of gene knockouts on chromatin accessibility are measured with single-cell CRISPR screens.

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.